# Georgetown University

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/georgetown-university/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 60.7 |
| Citations | 9,025,494 |
| City | Washington |
| Country | US |
| Description | Georgetown University is a research organisation in Washington, US. OpenAlex records 118,610 works and 9,025,494 citations for it. 20,516 researchers list it as their most recent affiliation. |
| Homepage | https://www.georgetown.edu |
| OpenAlex ID | https://openalex.org/I184565670 |
| Region | District of Columbia |
| Researchers | 20,516 |
| ROR ID | https://ror.org/05vzafd60 |
| Type | education |
| Works | 118,610 |

## University papers

Showing 12 of 285.

- [Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer](https://scholariq.org/papers/safety-activity-and-immune-correlates-of-anti-pd-1-antibody-in-cancer/)
- [Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery](https://scholariq.org/papers/transcatheter-aortic-valve-implantation-for-aortic-stenosis-in-patients-who/)
- [Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk Patients](https://scholariq.org/papers/transcatheter-versus-surgical-aortic-valve-replacement-in-high-risk-patients/)
- [Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer](https://scholariq.org/papers/trastuzumab-plus-adjuvant-chemotherapy-for-operable-her2-positive-breast-cancer/)
- [Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis](https://scholariq.org/papers/pathological-complete-response-and-long-term-clinical-benefit-in-breast-cancer/)
- [Optimal Medical Therapy with or without PCI for Stable Coronary Disease](https://scholariq.org/papers/optimal-medical-therapy-with-or-without-pci-for-stable-coronary-disease/)
- [Final Version of 2009 AJCC Melanoma Staging and Classification](https://scholariq.org/papers/final-version-of-2009-ajcc-melanoma-staging-and-classification/)
- [Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline](https://scholariq.org/papers/management-of-immune-related-adverse-events-in-patients-treated-with-immune/)
- [First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer](https://scholariq.org/papers/first-line-atezolizumab-plus-chemotherapy-in-extensive-stage-small-cell-lung/)
- [Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States](https://scholariq.org/papers/estimates-of-the-prevalence-of-arthritis-and-selected-musculoskeletal-disorders/)
- [Final Version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma](https://scholariq.org/papers/final-version-of-the-american-joint-committee-on-cancer-staging-system-for/)
- [Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma](https://scholariq.org/papers/avelumab-plus-axitinib-versus-sunitinib-for-advanced-renal-cell-carcinoma/)

## University researchers

Showing 15 of 17.

- [Stephen V. Liu](https://scholariq.org/researchers/stephen-v-liu/)
- [Guinevere F. Eden](https://scholariq.org/researchers/guinevere-f-eden/)
- [Michael Auerbach](https://scholariq.org/researchers/michael-auerbach/)
- [Magnus Lindberg](https://scholariq.org/researchers/magnus-lindberg/)
- [Gabriel Gondolesi](https://scholariq.org/researchers/gabriel-gondolesi/)
- [Rhonda B. Friedman](https://scholariq.org/researchers/rhonda-b-friedman/)
- [D. Lynn Flowers](https://scholariq.org/researchers/d-lynn-flowers/)
- [Mark Boukes](https://scholariq.org/researchers/mark-boukes/)
- [Andrew T. DeMarco](https://scholariq.org/researchers/andrew-t-demarco/)
- [Eileen M. Napoliello](https://scholariq.org/researchers/eileen-m-napoliello/)
- [Carolina Rumbo](https://scholariq.org/researchers/carolina-rumbo/)
- [Mackenzie E. Fama](https://scholariq.org/researchers/mackenzie-e-fama/)
- [Lauren Kahn](https://scholariq.org/researchers/lauren-kahn/)
- [Megan M. Luetje](https://scholariq.org/researchers/megan-m-luetje/)
- [Ronald Beaulieu](https://scholariq.org/researchers/ronald-beaulieu/)

## University top topics

Showing 8 of 22.

- [Neuroscience and Neuropharmacology Research](https://scholariq.org/topics/neuroscience-and-neuropharmacology-research/)
- [Healthcare Policy and Management](https://scholariq.org/topics/healthcare-policy-and-management/)
- [HIV/AIDS Research and Interventions](https://scholariq.org/topics/hiv-aids-research-and-interventions/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Ethics in medical practice](https://scholariq.org/topics/ethics-in-medical-practice/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Estrogen and related hormone effects](https://scholariq.org/topics/estrogen-and-related-hormone-effects/)
- [Receptor Mechanisms and Signaling](https://scholariq.org/topics/receptor-mechanisms-and-signaling/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.